2,3-Diphenylpropionic acids as potent VLA-4 antagonists

Area of Science:

• Medicinal Chemistry
• Immunology
• Pharmacology

Background:

• The VLA-4 (very late antigen-4) and VCAM-1 (vascular cell adhesion molecule-1) interaction plays a critical role in immune cell trafficking and inflammatory processes.
• Targeting this interaction is a key strategy for developing therapeutics for inflammatory and autoimmune diseases.

Purpose of the Study:

• To discover and characterize novel 2,3-diphenylpropionic acid derivatives as potent VLA-4 antagonists.
• To evaluate the efficacy of these compounds in inhibiting VLA-4/VCAM-1 mediated intercellular adhesion.

Main Methods:

• Structure-Activity Relationship (SAR) studies were conducted on a series of 2,3-diphenylpropionic acid derivatives.
• In vitro assays were used to measure the inhibition of VLA-4/VCAM-1 interaction and intercellular adhesion.
• Pharmacokinetic and oral bioavailability assessments were performed on promising compounds.

Main Results:

• Several 2,3-diphenylpropionic acid derivatives demonstrated potent VLA-4 antagonist activity.
• Compound 9cc exhibited significant inhibition of VLA-4/VCAM-1 mediated intercellular adhesion with an IC(50) of 1.7 nM.
• Compound 9cc displayed favorable pharmacokinetic properties and good oral bioavailability in preclinical assessments.

Conclusions:

• 2,3-diphenylpropionic acid derivatives represent a promising class of VLA-4 antagonists.
• Compound 9cc is a highly potent and orally bioavailable VLA-4 antagonist with therapeutic potential for inflammatory conditions.